This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Serona Sa. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Caroline Johnson-Leger: Innovator in Humanized Antibodies
Introduction
Caroline Johnson-Leger is a prominent inventor based in Saint Sixt, France. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. Her work focuses on addressing immune-mediated diseases, showcasing her commitment to advancing medical science.
Latest Patents
Caroline holds a patent for "Humanized antibodies against human IL-22RA." This invention relates to humanized antibodies that target human IL-22RA and their application in treating psoriasis and other immune-mediated diseases, such as psoriatic arthritis and atopic dermatitis. This patent highlights her innovative approach to tackling complex health issues.
Career Highlights
Throughout her career, Caroline has worked with notable companies, including Merck Serono SA. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the field of immunology.
Collaborations
Caroline has collaborated with various professionals in her field, including her coworker Roland Beckmann. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.
Conclusion
Caroline Johnson-Leger is a trailblazer in the development of humanized antibodies, with a focus on treating immune-mediated diseases. Her contributions to biotechnology and her innovative spirit continue to inspire advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile